Multi-Asset Growth Capital Holdings · vs · DACH Regional Venture Capital Funds
ACE & Company vs redalpine
Structured technology and market comparison · 2026
Direct Feature Comparison
ACE & Company · vs · redalpine| Attribute | ACACE & Company | REredalpine |
|---|---|---|
| Market Cluster / Sector | Multi-Asset Growth Capital Holdings | DACH Regional Venture Capital Funds |
| Business Model / Role | Private Equity, VC & Investor | Private Equity, VC & Investor |
| Platform Focus | Swiss private markets investment firm spanning secondaries, buyouts and venture. | Pan-European venture capital adviser backing science and technology companies. |
| Company Size | 10–49 employees | 10–49 employees |
| Headquarters | Switzerland | Switzerland |
| Year Founded | 2005 | 2006 |
| Dossier & Alternatives |
Analyze all overlapping signals and tech stacks for ACE & Company and redalpine
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between ACE & Company and redalpine?
When comparing ACE & Company and redalpine, both platforms operate within the Private Equity, VC & Investor ecosystem. ACE & Company is positioned as Swiss private markets investment firm spanning secondaries, buyouts and venture, whereas redalpine focuses on Pan-European venture capital adviser backing science and technology companies. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to ACE & Company and redalpine?
When evaluating ACE & Company and redalpine, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of ACE & Company and redalpine compare?
ACE & Company is headquartered in Switzerland (founded in 2005) with 10–49 employees. redalpine is based in Switzerland (founded in 2006) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: ACE & Company vs redalpine
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
ACE & Company
Recent Signals
No recent market signals documented for ACE & Company in the current tracking window.
redalpine
Recent Signals
- ·Trending Topics (DACH/CEE Innovation & Tech)Financials
Swiss VC Redalpine Raises $250 Million for A.I., Robotics and Biotech
Zurich-based venture capital firm Redalpine has closed its eighth early-stage fund, Redalpine Capital VIII (RAC VIII), at $250 million (approximately €225 million), its largest early-stage fund to date. The fund was oversubscribed, attracting both returning and new investors, including Aviva Investors, Flexstone Partners, and German development bank KfW. RAC VIII is 25% larger than its predecessor, which closed at $200 million in 2024, and will invest in 15-20 European startups at seed to Series A stages, with ticket sizes ranging from $1-15 million. Focus areas include AI, robotics, and biotech, with an emphasis on AI for drug discovery. Initial investments include Enact Intelligence, Helical, and Arlequin AI. Redalpine now manages over $1.4 billion in assets and has backed companies such as Mistral, N26, and Proxima Fusion. Managing Partner Sebastian Becker highlighted AI's potential to empower European founders, signaling a return of confidence in the region's ecosystem.
- Redalpine closed its eighth early-stage fund, RAC VIII, at $250 million (≈ €225 million), its largest to date.
- The fund was oversubscribed and is 25% larger than its predecessor, which raised $200 million in 2024.
- RAC VIII will invest in 15-20 European startups at seed to Series A, with checks of $1-15 million, focusing on AI, robotics, and biotech.
- ·Trending Topics (DACH/CEE Innovation & Tech)Health Tech / AI
Calliora raises $6M for AI hospital billing accuracy
Munich-based startup calliora has raised $6 million (approx. €5.1 million) in a pre-seed round led by Bertelsmann Healthcare Investments (BHI) and Swiss VC redalpine. The company's AI platform helps hospitals find billing errors before invoices are sent to health insurers. This comes as German hospitals face stricter audit quotas from 2027 under the GKV contribution rate stabilization law, where high error rates could lead to 100% of invoices being audited. The platform integrates with existing hospital systems, covering coding, case review, MD audit management, and controlling. According to calliora, the platform is already in regular operation in hospitals across five German states, reducing per-case workload by over half and closing more than 90% of identified gaps before billing. The funds will be used to grow the AI, engineering, and product teams. The startup was founded in 2023 by Frederik Träuble and Jonas Wildberger.
- calliora raised $6 million (€5.1 million) in a pre-seed round led by Bertelsmann Healthcare Investments and redalpine.
- The startup's AI platform detects billing errors in hospitals before invoices are sent to insurers.
- From 2027, German hospitals face higher audit quotas up to 100% under the GKV contribution rate stabilization law.
- ·RedalpineProduct & Platform Launch
A market that punishes narrative and rewards fundamentals: our current market view
Redalpine published a new market view article on September 29, 2026, discussing the current market dynamics.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners ACE & Company and redalpine share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks